ÂÜÀòÂÒÂ×

Geoffrey Parker is an accomplished financial executive with extensive experience in the life sciences and healthcare sectors. Currently serving as the Executive Vice President and Chief Financial Officer for Allogene Therapeutics since October 2023, Parker is also a Board Member for Better Therapeutics and Perrigo Company plc. Previously, Parker held multiple leadership roles, including Chief Operating Officer, Chief Financial Officer, and Executive Vice President at Tricida, Inc., and gained valuable experience as the Chief Financial Officer and Executive Vice President at Anacor Pharmaceuticals, where strategic efforts led to significant market capitalization growth. Parker's earlier career includes serving as a Managing Director at Goldman Sachs & Co., where a focus on healthcare investment banking resulted in over $100 billion in executed transactions. Parker holds an MBA from Stanford University and an A.B. in Economics and Engineering Sciences from Dartmouth College.